Pembrolizumab and Trametinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer and KRAS Gene Mutations

Name: Pembrolizumab and Trametinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer and KRAS Gene Mutations
Published: 2018
License: Public Domain

Jonathan Riess · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

kras gene mutation, metastatic non-squamous non-small cell lung carcinoma, recurrent non-squamous non-small cell lung carcinoma, stage iv non-small cell lung cancer ajcc v7, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Pembrolizumab and Trametinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer and KRAS Gene Mutations

Related documents